• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死溶栓与血管成形术(TAMI)试验:综述及护理要点

The thrombolysis and angioplasty in myocardial infarction (TAMI) trial: review and nursing implications.

作者信息

Pitts P, Fenwick B, Fromberg B

出版信息

Prog Cardiovasc Nurs. 1990 Apr-Jun;5(2):65-72.

PMID:2116622
Abstract

The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trial was a multicenter, randomized trial designed with the purpose of determining the clinical impact of immediate or deferred angioplasty on left ventricular function following successful myocardial reperfusion with tissue plasminogen activator (t-PA). Results from this trial indicate that immediate coronary angioplasty following successful thrombolysis, when coronary artery anatomy is suitable, offers no advantage over delayed elective angioplasty. The purpose of this article is to discuss and critically review the TAMI trial. Details of the trial will be discussed followed by a critique and implications for nursing.

摘要

心肌梗死溶栓与血管成形术(TAMI)试验是一项多中心随机试验,旨在确定在成功使用组织纤溶酶原激活剂(t-PA)实现心肌再灌注后,立即或延迟进行血管成形术对左心室功能的临床影响。该试验结果表明,在冠状动脉解剖结构合适时,溶栓成功后立即进行冠状动脉血管成形术相比延迟选择性血管成形术并无优势。本文旨在讨论并严格审视TAMI试验。将先讨论试验细节,随后进行评论并阐述其对护理工作的启示。

相似文献

1
The thrombolysis and angioplasty in myocardial infarction (TAMI) trial: review and nursing implications.心肌梗死溶栓与血管成形术(TAMI)试验:综述及护理要点
Prog Cardiovasc Nurs. 1990 Apr-Jun;5(2):65-72.
2
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.
N Engl J Med. 1987 Sep 3;317(10):581-8. doi: 10.1056/NEJM198709033171001.
3
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.既往有溶栓治疗禁忌证的患者采用不同再灌注策略的结果:直接经皮冠状动脉腔内血管成形术与组织型纤溶酶原激活剂的比较。心肌梗死直接经皮冠状动脉腔内血管成形术(PAMI)研究组。
Cathet Cardiovasc Diagn. 1996 Dec;39(4):333-9. doi: 10.1002/(SICI)1097-0304(199612)39:4<333::AID-CCD1>3.0.CO;2-E.
4
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.转运ST段抬高型心肌梗死患者进行机械再灌注治疗:随机试验的Meta回归分析
Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033.
5
[Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].[混合溶栓后备用经皮冠状动脉腔内血管成形术联合治疗急性心肌梗死患者的有效性]
J Cardiol. 2001 Apr;37(4):181-9.
6
Percutaneous transluminal coronary angioplasty for acute myocardial infarction.经皮腔内冠状动脉成形术治疗急性心肌梗死
Cardiol Clin. 1989 Nov;7(4):837-51.
7
Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.接受全身溶栓治疗或直接经皮冠状动脉腔内血管成形术的心肌梗死后晚期电位的患病率。
G Ital Cardiol. 1998 Jan;28(1):3-11.
8
[Indications of coronary angioplasty after thrombolysis].[溶栓后冠状动脉血管成形术的适应证]
Arch Mal Coeur Vaiss. 1995 Aug;88 Spec No 3:19-24.
9
Stenting versus thrombolysis in acute myocardial infarction trial (STAT).急性心肌梗死支架置入术与溶栓治疗对比试验(STAT)
Indian Heart J. 2001 May-Jun;53(3):375.
10
[Role of direct coronary angioplasty in the course of acute myocardial infarction].[直接冠状动脉血管成形术在急性心肌梗死病程中的作用]
Cardiologia. 1993 Dec;38(12 Suppl 1):129-42.